Compare Inovio Pharmaceuticals Inc (INO) vs Intel Corp (INTC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Inovio Pharmaceuticals Inc vs Intel Corp — how do they compare? Inovio Pharmaceuticals Inc trades at $1.08 (market cap $89.27M), while Intel Corp trades at $105.63 (market cap $487.82B). The key difference: Intel Corp is far larger — about 5464.5× Inovio Pharmaceuticals Inc's market cap, and Intel Corp pays a 2.24% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| INO | INTC | |
|---|---|---|
Market Cap | $89.27M | $487.82B |
Sector | Health | Technology |
52-Week High | $2.87 | $140.94 |
52-Week Low | $1.05 | $19.31 |
Enterprise Value | $60.28M | $500.07B |
Volume | — | 43,552,012 |
Dividend Yield | — | 2.24% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →About Intel Corp
Intel Corporation designs, manufactures, and sells computer components and related products. The Company major products include microprocessors, chipsets, embedded processors and microcontrollers, flash memory, graphic, network and communication, systems management software, conferencing, and digital imaging products.
Read more on INTC →
